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Radiofrequency Catheter Ablation of Hemodynamically Unstable 
Ventricular Tachycardia Associated with Systemic Sclerosis
Systemic sclerosis (SS) is a connective tissue disease and cardiac involvement is common. 
Primary cardiac involvement such as conduction system disturbances and arrhythmias can 
also occur. However, reports of sustained ventricular tachycardia (VT) are rare. We report a 
case of catheter ablation of sustained ventricular tachycardia in a patient with systemic 
sclerosis using a conventional mapping system. A 64-yr-old woman with a 10-yr history of 
SS was referred for management of her ventricular tachycardia. There was no structural 
abnormality in cardiac chambers. However, electrophysiologic study revealed electrical 
substrate of ventricular tachycardia which could be ablated with pacemapping and substrate 
mapping. This case demonstrated successful conventional mapping and catheter ablation 
in a hemodynamically unstable patient with SS.
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CASE REPORT
Cardiovascular Disorders
INTRODUCTION
Rhythm disturbances have been described in immunological 
and connective diseases (1). Systemic sclerosis (SS) is a fibrotic 
condition characterized by immunological abnormalities, vas-
cular injury and increased accumulation of extracellular matrix 
proteins (2). The heart is one of the major organs involved in SS 
and cardiac involvement has been a common finding at post-
mortem examination (3). Conduction disturbances as well as 
supraventricular tachycardia or ventricular extrasystoles com-
monly occur during Holter monitoring (4). Nonetheless, reports 
of sustained ventricular tachycardia (VT) are rare. The mecha-
nisms underlying ventricular arrhythmias in systemic sclerosis 
have not been well studied. In this report, we describe a case of 
successful treatment of hemodynamically unstable ventricular 
tachycardia in a patient with SS by catheter ablation with sub-
strate mapping.
CASE DESCRIPTION
A 64-yr-old woman with a 10-yr history of SS was referred for 
management of her ventricular tachycardia. The manifestations 
of SS included pulmonary interstitial fibrosis and mild pulmo-
nary hypertension managed by prednisolone and azathioprine. 
She was admitted to the emergency department on July 17, 
2009 and the initial electrocardiogram (ECG) revealed mono-
morphic wide QRS tachycardia which was well tolerated de-
spite a rate of 243 beats per minute (Fig. 1A). Wide QRS tachy-
cardia observed in the ECG showed a left bundle branch block, 
left axis deviation and atrioventricular dissociation. A profile of 
routine chemistry including myocardiac markers did not reveal 
any specific abnormalities. Antinuclear antibody screening and 
specific tests for antitopoisomerase III (anti-Scl-70) were posi-
tive and ESR was 94 mm/hr. Chest X-ray showed basal-pre-
dominant reticular abnormality. Sinus rhythm with normal QT 
interval (QTc: 453 ms) was restored with electrical cardiover-
sion (Fig. 1B). Echocardiography showed preserving LV ejec-
tion fraction and normal cardiac chamber size without struc-
tural abnormality of both ventricle. Mild pulmonary hyperten-
sion was monitored as 35 mmHg pulmonary artery pressure.
 On the 2nd day after admission, wide QRS tachycardia with 
the same morphology recurred. The tachycardia was persistent 
and the patient’s blood pressure dropped below 80 mmHg. Elec-
trical cardioversion was urgently performed and sinus rhythm 
was recovered.
 A coronary angiogram and electrophysiological study with 
radiofrequency catheter ablation were performed on the 3rd 
hospital day. There was no significant stenosis in coronary ar-
tery. During the electrophysiological test, sustained ventricular 
tachycardia of the same morphology with clinically document-
ed tachycardia was reproducibly induced by two ventricular 
extra stimuli (Fig. 2). The induced VTs were hemodynamically 
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unstable and do not permit activation mapping or entrainment 
during prolonged periods of tachycardia. Therefore, we per-
formed a substrate mapping during sinus rhythm and pace 
mapping instead of activation mapping or entrainment.
 During substrate mapping, delayed and isolated potential 
was found at the posterior base of the right ventricle (Fig. 3). 
Pacemapping in the area showed satisfactory 12-lead QRS 
matching with induced ventricular tachycardia (Fig. 4). Abla-
tion was started at the vicinity of the area, where the typical de-
layed and isolated potentials were found. Twelve radiofrequen-
cy currents were delivered at these sites in a temperature-con-
Fig. 1. Initial ECG at emergency room. (A) Twelve lead ECG on admission revealed 
sustained monomorphic VT with LBBB configulation and left axis deviation. (B) Sinus 
rhythm with incomplete RBBB and normal QT interval (QTc:453 ms) was restored by 
electrical cardioversion.
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Fig. 3. During substrate mapping in sinus rhythm, delayed and late potentials (black 
arrow) were identified at the mapping catheter.
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Fig. 2. Induced VT during the electrophysiologic study. This VT was morphologically 
identical with clinically documented VT (LBBB morphology and left axis deviation).
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Fig. 4. Pacemapping at the area of late potential showed good matching with in-
duced VT. (A) 12 lead ECG during pacemapping (B) 12 lead ECG duing ventricular 
tachycardia.
200 ms
A
B
A B
Chung H-H, et al. • Ventricular Tachycardia in Systemic Sclerosis
http://jkms.org  217http://dx.doi.org/10.3346/jkms.2012.27.2.215
trolled mode at 60°C with power limited to 50 W.
 After the final RF application, ventricular tachycardia was not 
induced either by the programmed extrastimuli or isoprotere-
nol infusion up to 10 μg/mim. After the procedure, there was 
no further inter/intraventricular conduction delay on ECG. Te-
lemetry monitoring revealed that the ventricular tachycardia 
did not recur and normal sinus rhythm was maintained.
 The patient was discharged and beta blockers, prednisolone 
and azathioprine were maintained. Follow-up observations are 
ongoing, and neither VT nor any cardiac symptoms have re-
curred.
DISCUSSION
This report describes a successful catheter ablation of a hemo-
dynamically unstable VT arising from the posterior base of right 
ventricle in a patient with SS. Cardiovascular involvement is 
common in SS. Tachyarrhythmia appears as a frequent clinical 
manifestation of SS-associated cardiovascular damage and a 
possible cause of sudden death (5). In one study, premature 
ventricular contraction was the most common arrhythmia and 
noted in 67% including PVCs in pairs in 20%, VT in 7%. The in-
cidence of sustained VT seems relatively low (6). However, if 
sustained VT occurs in these patients, it could be fatal. Our case 
was thought rare and interesting with a high possibility of sud-
den death due to sustained VT associated with SS.
 The mechanisms of tachyarrhythmia in SS are probably mul-
tiple. Among them, a re-entry mechanism due to diffuse myo-
cardial fibrosis would provide sustained monomorphic VT (7, 
8). Successful treatment with surgical cryoablation and catheter 
ablation have been reported. The implantable cardioverter de-
fibrillator has been used in survivors of cardiac arrest (8, 9). In 
our case, unlike VTs in previous reports, the VT was associated 
with hemodynamic instability. Therefore, we could not use ac-
tivation mapping or entrainment mapping during prolonged 
periods of tachycardia due to the hemodynamically unstable 
nature. In scar based reentrant VT, slow conduction takes place 
on the border of the scar tissue; therefore, abnormal and low 
amplitude electrograms have been recorded during sinus rhythm 
at these sites. As low-amplitude electrograms are recorded all 
along the scarred endocardial surface, they have low specificity 
for VT substrate identification. The exit site of the VT should be 
identified and targeted with ablation using pace-mapping at 
the border of the scar.
 Furthermore, a recent study (10) suggested that the contribu-
tion of scar to the electrophysiological abnormalities targeted 
for ablation of unstable VT differs between ischemic cardiomy-
opathy (ICM) and nonischemic cardiomyopathy (NICM). Mean 
total low voltage area in patients with ICM was larger than in 
NICM. Within the total low voltage area, late potentials were 
observed more frequently in ICM than in NICM in endocardi-
um and epicardium. Therefore, an approach incorporating late 
potential ablation and pace-mapping can be considered and 
electroanatomical mapping can be an alternative in patients 
with NICM.
 This case demonstrated successful conventional mapping 
and catheter ablation in a patient with SS, despite a hemody-
namically unstable state. In the future, we suggest the need for 
her to insert implantable cardioverter defibrillator.
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